Flavia Borellini - Jun 20, 2024 Form 4/A Insider Report for Revolution Medicines, Inc. (RVMD)

Role
Director
Signature
/s/ Jack Anders, as Attorney-in-fact for Flavia Borellini
Stock symbol
RVMD
Transactions as of
Jun 20, 2024
Transactions value $
$0
Form type
4/A
Date filed
6/28/2024, 05:08 PM
Date Of Original Report
Jun 24, 2024
Previous filing
Jun 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVMD Common Stock Award $0 +4.25K +24.09% $0.00 21.9K Jun 20, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RVMD Stock Option (Right to Buy) Award $0 +16K $0.00 16K Jun 20, 2024 Common Stock 16K $37.54 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 4,851 restricted stock units ("RSUs").
F2 Shares subject to the Stock Option shall vest in full on the earlier of (i) the first anniversary of June 20, 2024 or (ii) immediately prior to the Issuer's annual meeting of stockholders following the date of grant, subject to the Reporting Person continuing in service through the vesting date.

Remarks:

On June 24, 2024, the Reporting Person filed a Form 4 that inadvertently reported incorrect amounts for the RSU and Stock Option awards granted to the Reporting Person on June 20, 2024. The correct amounts and footnote information are reflected in this amendment.